Terms: = Kidney tumors AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
17 results:
1. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
Jiang Z; Wang H; Wang S; Guan C; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma.
Wang J; Ye J; Zhao X; Li X; Ma X
World J Surg Oncol; 2023 Jul; 21(1):211. PubMed ID: 37480143
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Wu Z; Chen H; Chen Q; Ge S; Yu N; Campi R; Gómez Rivas J; Autorino R; Rouprêt M; Psutka SP; Mehrazin R; Porpiglia F; Bensalah K; Black PC; Mir MC; Minervini A; Djaladat H; Margulis V; Bertolo R; Caliò A; Carbonara U; Amparore D; Borregales LD; Ciccarese C; Diana P; Erdem S; Marandino L; Marchioni M; Muselaers CHJ; Palumbo C; Pavan N; Pecoraro A; Roussel E; Warren H; Pandolfo SD; Chen R; Zhou W; Zhai W; He M; Li Y; Han B; Wan J; Zeng X; Yan J; Fu Y; Ji C; Fan X; Zhang G; Zhao C; Jing T; Wang A; Feng C; Zhao H; Sun D; Wang L; Tai S; Zhang C; Chen S; Liu Y; Xu Z; Wang H; Gao J; Wang F; Cheng J; Miao H; Rao Q; Wang J; Xu N; Wang G; Liang C; Liu Z; Xia D; Jiang J; Zu X; Chen M; Guo H; Qin W; Wang Z; Xue W; Shi B; Zhou X; Wang S; Zheng J; Ge J; Feng X; Li M; Chen C; Qu L; Wang L;
Eur Urol Oncol; 2024 Feb; 7(1):112-121. PubMed ID: 37468393
[TBL] [Abstract] [Full Text] [Related]
4. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract] [Full Text] [Related]
5. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma.
Balci M; Glaser ZA; Chang SS; Herrell SD; Barocas DA; Keegan KA; Moses KA; Resnick MJ; Smith JA; Penson DF; Scarpato K; Clark PE
J Cancer Res Ther; 2021; 17(2):420-425. PubMed ID: 34121687
[TBL] [Abstract] [Full Text] [Related]
6. Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma.
Yoshida T; Kobayashi T; Kawaura T; Miyake M; Ito K; Okuno H; Murota T; Makita N; Kawakita M; Kawa G; Kitawaki T; Fujimoto K; Matsuyama H; Shiina H; Azuma H; Ogawa O; Kinoshita H; Matsuda T
Cancer Med; 2020 Jun; 9(11):3733-3741. PubMed ID: 32253820
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract] [Full Text] [Related]
8. [Triple expressor lymphoma in a kidney transplant patient].
Aránguiz N; Vega J
Rev Med Chil; 2019 Feb; 147(2):247-250. PubMed ID: 31095175
[TBL] [Abstract] [Full Text] [Related]
9. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
10. p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-up.
Zhang H; Zhao Y; Sun P; Zhao M; Su Z; Jin X; Song W
Carcinogenesis; 2018 Mar; 39(3):368-374. PubMed ID: 29346503
[TBL] [Abstract] [Full Text] [Related]
11. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
[TBL] [Abstract] [Full Text] [Related]
12. Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.
Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Perez JR; Agarwal N; Vogelzang NJ
Clin Genitourin Cancer; 2017 Aug; 15(4):e573-e582. PubMed ID: 28139444
[TBL] [Abstract] [Full Text] [Related]
13. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract] [Full Text] [Related]
14. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract] [Full Text] [Related]
15. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract] [Full Text] [Related]
16. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
Gore ME; Szczylik C; Porta C; Bracarda S; Bjarnason GA; Oudard S; Hariharan S; Lee SH; Haanen J; Castellano D; Vrdoljak E; Schöffski P; Mainwaring P; Nieto A; Yuan J; Bukowski R
Lancet Oncol; 2009 Aug; 10(8):757-63. PubMed ID: 19615940
[TBL] [Abstract] [Full Text] [Related]
17. Renal masses detected by general health checkup.
Tsuboi N; Horiuchi K; Kimura G; Kondoh Y; Yoshida K; Nishimura T; Akimoto M; Miyashita T; Subosawa T
Int J Urol; 2000 Nov; 7(11):404-8. PubMed ID: 11144650
[TBL] [Abstract] [Full Text] [Related]
